IASLC retweeted
Happy 52nd Birthday, IASLC! 🎉
52 years of bringing together the global community dedicated to advancing lung cancer research and improving patient care.
From all of us on the IASLC Communications Committee, we're happy to celebrate this milestone and proud to help share the science, stories, and achievements of this incredible community!
Here's to many more years of collaboration and progress together!
@IASLC
@MattSmeltzer
#IASLC #LungCancer #LungCancerResearch
IASLC retweeted
I had so much fun recording #WCLC26 highlights in Arabic alongside wonderful colleagues from Palestine, Jordan, Egypt, Australia and USA 🌍🎙
🌍 #WCLC26 highlights, now in Arabic!
In the latest #LungCancerConsidered episode, host Dr. @NaglaAKarimMD is joined by Drs. Bashir Abu Aqeel, @AlrabiKamal, Riad Abdel Jalil, Ahmed Magdy Rabea, Myriam Saadi, and Hussein Soudy to revisit highlights from the 2026 World Conference on Lung Cancer.
🎧 Listen to the episode: bit.ly/4i8tvgc
#LungCancer #ThoracicOncology
🌍 #WCLC26 highlights, now in Arabic!
In the latest #LungCancerConsidered episode, host Dr. @NaglaAKarimMD is joined by Drs. Bashir Abu Aqeel, @AlrabiKamal, Riad Abdel Jalil, Ahmed Magdy Rabea, Myriam Saadi, and Hussein Soudy to revisit highlights from the 2026 World Conference on Lung Cancer.
🎧 Listen to the episode: bit.ly/4i8tvgc
#LungCancer #ThoracicOncology
IASLC retweeted
Pulmonary large cell neuroendocrine carcinoma is clinically and molecularly distinct from small cell #lungcancer. In this large retrospective series, Choudhury et al. found that there is no clear association of benefit observed through the application of molecularly classified standard treatments of patients with LCNEC.
Guidelines for the development of prospective trials of novel therapeutics may be helpful here.
Read more: bit.ly/4z1rE3R
#LungCancerResearch #JTO
What matters most to the #radiology community?
IASLC is seeking input from radiology professionals to help guide future education, research, leadership and networking opportunities.
Take our brief survey: bit.ly/4yaE1JV
From attending IASLC meetings as a postdoctoral fellow to serving on our Board of Directors, what a journey!
As we celebrate 52 years of IASLC, @triparnasen shares how the organization has shaped her career and the special connections that make our global community so meaningful.
Here's to the people, partnerships, and shared passion that have made 52 years of progress possible! 🎂
#IASLC52 #ThoracicOncology
🎂 IASLC turns 52 today, and we're celebrating with a gift!
Never been an IASLC member? Claim a FREE Associate Membership with code [IASLCBirthday2026].
Join our global thoracic oncology community!
Access your membership: bit.ly/4iFRpB8
#IASLC52
🎧 #WCLC26 insights from Taiwan!
Dr. Kuan-Yu Chen joins Drs. Bin-Chi Liao, Mong-Wei Lin & Po-Lan Su for a Mandarin-language discussion of key conference highlights.
Listen: bit.ly/3UAtEkJ
#LungCancerConsidered #LungCancer #ThoracicOncology #Mandarin
⏰ The IASLC Guidelines Survey closes today!
Help us better understand how thoracic cancer clinical guidelines are used in practice and where challenges remain.
Share your perspective: bit.ly/4jIYsd7
🔬 Pumitamig plus elfe-D demonstrated encouraging early efficacy in SCLC across all lines of therapy and dose levels.
🔗 Read the insights from a #WCLC26 presentation by @AdamJSchoenfeld in ILCN: bit.ly/4hLUSxC
#LCSM
🎉 52 years of advancing #lungcancer research, education, and collaboration!
As we celebrate IASLC's upcoming birthday, we're putting your knowledge to the test!
Think you know the answer to our latest trivia question? 🤔
Reply below to enter our IASLC merch drawing!
#IASLC52
IASLC retweeted
I am looking forward to connecting with colleagues across Latin America and advancing care for our patients with thoracic cancers.
See you there at the LALCA & ITMIG 2026 Conference, November 12–14 in São Paulo, Brazil.
See you there! #LALCA26 @WinshipAtEmory @IASLC
VIKTOR is evolving! 🤖
First launched in 2025, IASLC's thoracic oncology knowledge platform now offers new capabilities with VIKTOR 2.0, including natural language searching, expanded cell line data, and AI-supported knowledge access.
Exclusive to full IASLC members. Explore now: iaslc.org/viktor
Trade the winter chill for Scottsdale sunshine! ☀️
Join us Dec. 4–6 at #NACLC26 for the latest thoracic oncology research, clinical insights, and opportunities to connect with colleagues.
Register: bit.ly/3VHjvD7
#LungCancer
IASLC retweeted
After developing digital machine learning models to quantify tumor bed area and residual viable tumor, Dacic et al. compared these results to previously published assessments of pathological response from pathologists from the IASLC's reproducibility study.
Their findings support the utility of machine learning algorithms for evaluating pathological response in patients with NSCLC.
Read the report: bit.ly/3VEKNKq
#LungCancerResearch #JTO
Two conferences, one registration! 🌎
Join us in São Paulo, November 12–14, for #LALCA26 and #ITMIG26. Your registration includes access to sessions from both conferences, offering more opportunities to learn and connect.
Register: bit.ly/4e72Zm4
IASLC retweeted
Thrilled and honored to receive the 2026 Career Development Award from @LC_Initiative_ ! Our project, TRACE-SCLC, will test whether an ultrasensitive, tumor-informed blood test can detect progression in ES-SCLC before scans do. Excited to get started!
@SclcSMASHERS @DukeCancer @DukeHealth
Your research could be part of #TTLC27!
Fellows and junior faculty are invited to submit abstracts and share ongoing research and emerging findings with the thoracic oncology community.
📅 Deadline: Nov. 23
Learn more and submit now: bit.ly/4jHRxB1
